Pfizer

JPM23: Vaccine developers as dealmakers, Gilead’s trial tea leaves and building platform companies
BioPharma Dive
Tue, 01/10/23 - 10:47 am
JPMHC 2023
vaccines
COVID-19
Moderna Therapeutics
Pfizer
Gilead Sciences
FDA grants priority reviews for Pfizer's Prevnar 20 for kids and Roche lymphoma candidate
Endpoints
Sun, 01/8/23 - 09:59 pm
FDA
priority review
Pfizer
Prevnar 20
vaccines
Roche
bispecific antibodies
glofitamab
lymphoma
Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report
Fierce Pharma
Sun, 01/8/23 - 09:57 pm
Pfizer
Merck
JNJ
Novo Nordisk
AstraZeneca
Pfizer pivots from early-stage rare disease R&D, shifting to external innovation and putting assets up for sale
Fierce Biotech
Fri, 01/6/23 - 10:09 am
Pfizer
R&D
externalization
gene therapy
Rare Diseases
Moderna sprints toward RSV podium behind GSK, Pfizer, with eyes on combo vax
Fierce Biotech
Thu, 01/5/23 - 10:14 am
Moderna Therapeutics
RSV
GSK
Pfizer
vaccines
The biggest-selling pharma companies of 2023
EP Vantage
Wed, 01/4/23 - 05:20 pm
Pfizer
Merck
JNJ
Novartis
AbbVie
Roche
Astellas loses bid to block Lexiscan generics in US
Pharmaphorum
Wed, 01/4/23 - 05:15 pm
legal
Astellas
Pfizer
Lexiscan
patents
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
clinical trials
Alzheimer's disease
obesity
Huntington's disease
M&A
AstraZeneca
Daiichi Sankyo
Nimbus Therapeutics
Takeda
Eli Lilly
Sanofi
Regeneron
Moderna Therapeutics
Gilead Sciences
Pfizer
Roivant
Alnylam
uniQure
Weak data as booster for Comirnaty close off opportunity for Valneva's COVID-19 vaccine
Fierce Biotech
Tue, 01/3/23 - 10:25 am
Valneva
Pfizer
BioNTech
vaccines
boosters
COVID-29
Pfizer says hemophilia B gene therapy controlled bleeding in key study
BioPharma Dive
Fri, 12/30/22 - 10:42 am
Pfizer
gene therapy
hemophilia B
fidanacogene elaparvovec
FDA accepts BLA for Pfizer’s meningococcal vaccine candidate
Pharmaceutical Business Review
Fri, 12/30/22 - 10:36 am
Pfizer
FDA
vaccines
meningococcal disease
MenABCWY
Pfizer Doubles Down on AI/ML to Bring Transformative Medicines to Patients
BioSpace
Wed, 12/21/22 - 12:38 pm
Pfizer
artificial intelligence
machine learning
innovation
Pfizer advances diabetes, obesity drug hopeful into mid-stage testing
BioPharma Dive
Wed, 12/21/22 - 12:34 pm
Pfizer
diabetes
obesity
PF-07081532
Sosei Heptares
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
AstraZeneca
Daiichi Sankyo
Pfizer
Roche
CSL
uniQure
Novo Nordisk
Eli Lilly
Pfizer's Supreme Court challenge of US kickback law is 'far-fetched,' HHS says
Fierce Pharma
Thu, 12/15/22 - 11:21 pm
Pfizer
legal
kickbacks
Supreme Court
rebates
Medicare
Lilly and Pfizer fight for new territory in obesity and diabetes
EP Vantage
Thu, 12/15/22 - 10:46 am
Eli Lilly
Pfizer
obesity
diabetes
orforglipron
Mounjaro
Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
M&A
Amgen
Horizon Therapeutics
Pfizer
Biohaven
Global Blood Therapeutics
Bristol Myers Squibb
Turning Point Therapeutics
ChemoCentryx
Pfizer's plan for $110+ Covid-19 vaccines riles up US senators
Endpoints
Wed, 12/14/22 - 10:23 am
Pfizer
COVID-19
vaccines
drug pricing
Senate
Pfizer projects mRNA vaccine sales will hover around $15B by 2030
Endpoints
Tue, 12/13/22 - 11:58 pm
Pfizer
MRNA
vaccines
ASH: In next BCMA myeloma race, Gracell dazzles with 100% response rate as Pfizer, BMS place their bets
Fierce Biotech
Mon, 12/12/22 - 10:33 am
ASH 2022
Gracell
CAR-T
Multiple Myeloma
Bristol Myers Squibb
Pfizer

Pages